by UBS

The rise of anti-obesity drugs could have far-reaching effects

The use of anti-obesity drugs is soaring, and that trend has the potential to affect a variety of industries. New food products are being designed to better suit the diets of those on the drugs, while some retailers have noticed a change in demand for differing clothing sizes. And as the FT’s science editor Michael Peel explains, widespread use of anti-obesity drugs could even affect a nation’s economic performance.

We think you'll like this

DISCOVER

More from FT Transact

FT Transact

FT Channels, a partnership destination that combines impactful and enriching multimedia content to spark curiosity and encourage discovery. Each vertical brings expert insights from the Financial Times and our Partners into the most pressing issues of our time.


FT Transact turns a spotlight on the future of capital, exploring what’s driving transactional transformation - from trends in ecommerce, fintech and ESG investing, to the corporate innovators working to build the future of finance. This multimedia series alternates between independent reporting from FT journalists and expert commentary from UBS